Skip to Main Content

Paper Details

Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome.
Pharmacoeconomics
5
2020
Author NameAffiliation
David L VeenstraDepartment of Pharmacy, Policy and Economics (CHOICE) Institute, University of Washington
  • 1 - 1

Datasets

Release 1.2